Antibodies [CS] class drugs

2 results
  • tecentriq - atezolizumab injection, solution

    (Atezolizumab)
    Genentech, Inc.
    Tecentriq is a PD-L1 blocking antibody for treating several cancers in adults: non-small cell and small cell lung cancer, hepatocellular carcinoma, BRAF V600-positive melanoma, alveolar soft part sarcoma (including pediatric patients age 2+), and muscle invasive bladder cancer.